The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

  • End date
    Dec 14, 2022
  • participants needed
  • sponsor
    University of Chicago
Updated on 26 January 2021


The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.

Condition Gastroenteritis, Intestinal Diseases, Coagulopathy, Blood disorder, Autoimmune disease, Heart disease, Hepatitis C, Hepatitis C virus, Autoimmunity, Cardiovascular Disease, Inflammatory bowel disease, Patients Undergoing Routine Health Care, Inflammatory Disease, Non-Metastatic Neoplasm, Inflammatory Disorder, Bowel Dysfunction, Hematological Disorders, Cardiac Disease, Non-Metastatic Neoplasm, Non-Metastatic Neoplasm, inflammatory bowel diseases, cardiac diseases, heart diseases, cardiac disorders, cardiac disorder, heart disorder, autoimmune diseases, autoimmune disorder, autoimmune disorders, clotting, bleeding diathesis, bleeding tendency, blood coagulation disorders, coagulopathies, bleeding disorders, coagulation disorder, bleeding disorder, clotting disorders, blood clotting disorders, Non-Metastatic Neoplasm, Non-Metastatic Neoplasm, Non-Metastatic Neoplasm
Clinical Study IdentifierNCT01280825
SponsorUniversity of Chicago
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial
Life expectancy of at least 3 years
Must be 18 years or older
Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years
Patients with certain diseases, or likely to receive or be receiving certain drugs, will be targeted particularly for enrollment in order to enrich the study for patients likely to have pharmacogenetically relevant interactions, including, but not limited
Patients requiring specialized cardiology care
Patients with inflammatory bowel diseases
Patients with systemic autoimmune or inflammatory diseases
Patients requiring long-term oral anticoagulation
Patients with hepatitis C
Patients with non-metastatic cancer

Exclusion Criteria

Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years
Patients who have undergone, or are being actively considered for, liver or kidney transplantation
Inability to understand and give informed consent to participate
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note